Improvement of neurogenic urinary dysfunctions in female rats treated with an injection of botulinum toxin A at the epicenter of the spinal cord injured site.
Abstract
[OBJECTIVE] To assess the effect of an injection of botulinum toxin A (BoNT/A) at the epicenter of the spinal cord injury (SCI) site on the recovery of lower urinary tract function in female rats with thoracic SCI.
[MATERIALS AND METHODS] Twenty-four female Wistar rats with Sham (laminectomy at T8/T9 level) or SCI (at T8/T9; 30 g compression for 5 s) were assigned into Sham-SS (injected with 5 µL of saline solution), Sham-BoNT/A (injected with 15 pg/rat, equivalent to 7.5 Units/kg of BoNT/A in 5 µL volume), SCI-SS (injured and injected with saline), SCI-BoNT/A (injured and injected with BoNT/A), N = 6 per group. Weekly evaluation of stereotyped micturition behavior, hind-limb nociception, and locomotor activity was performed 1 week before and during 6 weeks after surgery. Subsequently, all groups underwent simultaneous electromyography of the external urethral sphincter (EUS-EMG) and cystometric (CMG) studies.
[RESULTS] A compression SCI at the T8/T9 thoracic level significantly impairs sensory and locomotive functions, as well as stereotyped micturition behavior. However, these impairments were improved by BoNT/A injection after SCI. Neither injections of saline solution nor BoNT/A had an appreciable effect on the same parameters evaluated in the Sham groups. The combined EUS-EMG and CMG evaluations revealed important improvements of lower urinary tract physiology, particularly a reduction in the frequency of non-voiding contractions and the properties of EUS bursting activity indicated as the amplitude of the EUS-EMG signal and duration of burst electrical activity during effective voiding.
[CONCLUSION] The severe impairments on sensory and locomotive functions as well stereotyped micturition caused by an SCI could be potentially attenuated by an injection of a small amount of BoNT/A directly into the epicenter of the SCI region. A reduction in the release of neurotoxic neurotransmitters requiring the SNARE complex may be the mechanism triggered by BoNT/A to reduce neurotoxicity and hyperexcitability created in the SCI area to improve the survival of spinal cord cells involved in micturition.
[MATERIALS AND METHODS] Twenty-four female Wistar rats with Sham (laminectomy at T8/T9 level) or SCI (at T8/T9; 30 g compression for 5 s) were assigned into Sham-SS (injected with 5 µL of saline solution), Sham-BoNT/A (injected with 15 pg/rat, equivalent to 7.5 Units/kg of BoNT/A in 5 µL volume), SCI-SS (injured and injected with saline), SCI-BoNT/A (injured and injected with BoNT/A), N = 6 per group. Weekly evaluation of stereotyped micturition behavior, hind-limb nociception, and locomotor activity was performed 1 week before and during 6 weeks after surgery. Subsequently, all groups underwent simultaneous electromyography of the external urethral sphincter (EUS-EMG) and cystometric (CMG) studies.
[RESULTS] A compression SCI at the T8/T9 thoracic level significantly impairs sensory and locomotive functions, as well as stereotyped micturition behavior. However, these impairments were improved by BoNT/A injection after SCI. Neither injections of saline solution nor BoNT/A had an appreciable effect on the same parameters evaluated in the Sham groups. The combined EUS-EMG and CMG evaluations revealed important improvements of lower urinary tract physiology, particularly a reduction in the frequency of non-voiding contractions and the properties of EUS bursting activity indicated as the amplitude of the EUS-EMG signal and duration of burst electrical activity during effective voiding.
[CONCLUSION] The severe impairments on sensory and locomotive functions as well stereotyped micturition caused by an SCI could be potentially attenuated by an injection of a small amount of BoNT/A directly into the epicenter of the SCI region. A reduction in the release of neurotoxic neurotransmitters requiring the SNARE complex may be the mechanism triggered by BoNT/A to reduce neurotoxicity and hyperexcitability created in the SCI area to improve the survival of spinal cord cells involved in micturition.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 해부 | urinary
|
scispacy | 1 | ||
| 해부 | spinal cord
|
scispacy | 1 | ||
| 해부 | urinary tract
|
scispacy | 1 | ||
| 해부 | hind-limb
|
scispacy | 1 | ||
| 해부 | CMG
|
scispacy | 1 | ||
| 해부 | thoracic
|
scispacy | 1 | ||
| 해부 | SCI
→ spinal cord injury
|
scispacy | 1 | ||
| 해부 | spinal cord cells
|
scispacy | 1 | ||
| 합병증 | thoracic SCI
|
scispacy | 1 | ||
| 합병증 | urethral sphincter
|
scispacy | 1 | ||
| 약물 | botulinum toxin A
|
C0006050
botulinum toxin type A
|
scispacy | 1 | |
| 약물 | pg/rat
|
scispacy | 1 | ||
| 약물 | BoNT/A
→ botulinum toxin A
|
C0006050
botulinum toxin type A
|
scispacy | 1 | |
| 약물 | CMG
|
scispacy | 1 | ||
| 약물 | [OBJECTIVE]
|
scispacy | 1 | ||
| 약물 | saline
|
scispacy | 1 | ||
| 약물 | Sham-BoNT/A
|
scispacy | 1 | ||
| 약물 | Units/kg
|
scispacy | 1 | ||
| 약물 | [RESULTS] A
|
scispacy | 1 | ||
| 질환 | neurogenic urinary dysfunctions
|
scispacy | 1 | ||
| 질환 | cord injury
|
scispacy | 1 | ||
| 질환 | thoracic SCI
|
scispacy | 1 | ||
| 질환 | lower urinary tract physiology
|
C0042031
Urinary Tract Physiology
|
scispacy | 1 | |
| 질환 | impairments on sensory and locomotive functions
|
scispacy | 1 | ||
| 질환 | neurotoxic
|
scispacy | 1 | ||
| 질환 | neurotoxicity
|
C0235032
Neurotoxicity Syndromes
|
scispacy | 1 | |
| 질환 | hyperexcitability
|
C0814034
Neuronal Hyperexcitability
|
scispacy | 1 | |
| 질환 | SCI
→ spinal cord injury
|
scispacy | 1 | ||
| 질환 | EUS-EMG
|
scispacy | 1 | ||
| 기타 | rats
|
scispacy | 1 | ||
| 기타 | botulinum toxin A
|
scispacy | 1 | ||
| 기타 | BoNT/A
→ botulinum toxin A
|
scispacy | 1 | ||
| 기타 | Wistar rats
|
scispacy | 1 | ||
| 기타 | SCI-BoNT/A
|
scispacy | 1 | ||
| 기타 | SCI
→ spinal cord injury
|
scispacy | 1 | ||
| 기타 | CMG
|
scispacy | 1 | ||
| 기타 | EUS-EMG
|
scispacy | 1 | ||
| 기타 | SNARE
|
scispacy | 1 | ||
| 기타 | SCI area
|
scispacy | 1 |
MeSH Terms
Rats; Female; Animals; Botulinum Toxins, Type A; Saline Solution; Rats, Wistar; Urinary Bladder; Urination; Spinal Cord Injuries
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.